Compare CSWC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSWC | SDGR |
|---|---|---|
| Founded | 1961 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2020 |
| Metric | CSWC | SDGR |
|---|---|---|
| Price | $22.09 | $17.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $23.50 | ★ $26.25 |
| AVG Volume (30 Days) | 502.3K | ★ 823.3K |
| Earning Date | 02-02-2026 | 11-05-2025 |
| Dividend Yield | ★ 11.70% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.62 | N/A |
| Revenue | $217,271,000.00 | ★ $256,951,000.00 |
| Revenue This Year | $13.78 | $23.69 |
| Revenue Next Year | $7.08 | $20.46 |
| P/E Ratio | $13.50 | ★ N/A |
| Revenue Growth | 11.39 | ★ 32.90 |
| 52 Week Low | $17.46 | $15.99 |
| 52 Week High | $23.86 | $28.47 |
| Indicator | CSWC | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 61.72 | 47.75 |
| Support Level | $21.33 | $17.62 |
| Resistance Level | $22.52 | $19.44 |
| Average True Range (ATR) | 0.28 | 0.77 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 62.76 | 34.30 |
Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.